Andean Precious Metals (CVE:APM) PT Raised to C$1.70 at Desjardins

Andean Precious Metals (CVE:APM) had its price objective boosted by investment analysts at Desjardins from C$1.60 to C$1.70 in a note issued to investors on Tuesday, BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Desjardins’ price objective suggests a potential upside of 70.00% from the stock’s current price.

Andean Precious Metals Stock Performance

Shares of APM stock opened at C$1.00 on Tuesday. The stock has a market capitalization of C$149.36 million, a P/E ratio of 2.63 and a beta of 1.14. Andean Precious Metals has a 1 year low of C$0.53 and a 1 year high of C$1.11. The company’s 50 day moving average is C$1.02.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.